Word

XERNA

Status

Pending

Status Code

733

Status Date

Wednesday, March 13, 2024

Serial Number

90635722

Mark Type

4000

Filing Date

Friday, April 9, 2021

Published for Opposition

Tuesday, January 18, 2022

Trademark Owner History

OncXerna Therapeutics, Inc. - Owner At Publication

Classifications

9 Downloadable computer software for use in analyzing, managing, visualizing and storing data; downloadable computer software for measuring, testing, analyzing, and processing biological samples

5 Chemical preparations for laboratory and diagnostic use in the medical, veterinary or pharmaceutical field, namely, chemical preparations for use in relation to the detection, treatment and monitoring of cancer, inherited disease, genetic predispositions, drug responses, and monitoring of tumors; diagnostic preparations for medical, veterinary or pharmaceutical use for use in relation to the detection, treatment and monitoring of cancer, inherited disease, genetic predispositions, drug responses, monitoring of tumors, and analysis of DNA or RNA; kits comprising chemical preparations and diagnostic preparations for medical, veterinary or pharmaceutical use for use in relation to the detection, treatment or monitoring of cancer, inherited disease, genetic predispositions, drug responses, monitoring of tumors and analysis of DNA or RNA; kits comprising primarily of assays, reagents, enzymes and/or nucleotides for medical diagnostic use

1 Chemical preparations for use in analyzing DNA or RNA for scientific purposes; kits comprising chemical preparations for use in analyzing DNA or RNA for scientific purposes

10 Medical test kits, comprising test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens, used in connection with the detection of gene mutations associated with cancers and RNA expression levels

42 Medical tests, namely, providing reference and clinical laboratory tests which detect gene mutations associated with cancer, and RNA expression levels; pharmaceutical research services; providing an on-line searchable database in the field of life science for scientific research purposes; providing medical and scientific research information in the fields of pharmaceuticals, molecular diagnostics, and genetics; scientific and medical laboratory services; providing use of non-downloadable cloud-based computer software for measuring, testing, analyzing, and processing biological samples

Trademark Events

Mar 14, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 13, 2024

Sou Extension 4 Granted

Mar 13, 2024

Sou Extension 4 Filed

Mar 13, 2024

Sou Teas Extension Received

Sep 16, 2023

Notice Of Approval Of Extension Request E-Mailed

Sep 14, 2023

Sou Extension 3 Granted

Sep 14, 2023

Sou Extension 3 Filed

Sep 14, 2023

Sou Teas Extension Received

Feb 24, 2023

Notice Of Approval Of Extension Request E-Mailed

Feb 22, 2023

Sou Extension 2 Granted

Feb 22, 2023

Sou Extension 2 Filed

Feb 22, 2023

Sou Teas Extension Received

Sep 10, 2022

Notice Of Approval Of Extension Request E-Mailed

Sep 8, 2022

Sou Extension 1 Granted

Sep 8, 2022

Sou Extension 1 Filed

Sep 8, 2022

Sou Teas Extension Received

Mar 15, 2022

Noa E-Mailed - Sou Required From Applicant

Jan 18, 2022

Official Gazette Publication Confirmation E-Mailed

Jan 18, 2022

Published For Opposition

Dec 29, 2021

Notification Of Notice Of Publication E-Mailed

Dec 15, 2021

Approved For Pub - Principal Register

Dec 15, 2021

Examiner's Amendment Entered

Dec 15, 2021

Notification Of Examiners Amendment E-Mailed

Dec 15, 2021

Examiners Amendment E-Mailed

Dec 15, 2021

Examiners Amendment -Written

Dec 6, 2021

Notification Of Non-Final Action E-Mailed

Dec 6, 2021

Non-Final Action E-Mailed

Dec 6, 2021

Non-Final Action Written

Nov 29, 2021

Assigned To Examiner

Jul 17, 2021

New Application Office Supplied Data Entered

Apr 13, 2021

New Application Entered